Treatment with immune checkpoint inhibitors (ICIs) and the occurrence of colitis among patients with melanoma in the United States

被引：0
|
作者：
Pan, Xianying
Verma, Devashish
Zhang, Jiayin
Pathak, Raminder
Monda, Stefano
Ma, Xiaomei
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-736
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
736
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Approaches to the description of patterns of care after colitis diagnosis in melanoma patients treated with immune checkpoint inhibitors (ICIs)
    Pan, Xianying
    Kulkarni, Vishal
    Pathak, Raminder
    Monda, Stefano
    Hasan, Imran
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 39 - 39
  • [2] Efficacy of immune checkpoint inhibitors (ICIs) for in-transit melanoma.
    Tie, Emilia Nan
    Lai-Kwon, Julia Elizabeth
    Na, Lumine
    Rtshiladze, Michael Alexander
    Bozzi, James
    Read, Tavis
    Atkinson, Victoria
    Au-Yeung, George
    Long, Georgina V.
    McArthur, Grant A.
    Sandhu, Shahneen Kaur
    Saw, Robyn
    Walpole, Euan Thomas
    Menzies, Alexander M.
    Smithers, B. Mark
    Gyorki, David E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Association of corticosteroid (CS) exposure with treatment failure in patients (pts) with advanced melanoma treated with immune checkpoint inhibitors (ICIs)
    Le, H. M. L.
    Pozas Perez, J.
    San Roman Gil, M. V.
    Serrano Domingo, J. J.
    Larkin, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S691 - S691
  • [4] Clinical characteristics and treatment efficacy of immune checkpoint inhibitors (ICIs) in patients with ICIs-induced Adrenal insufficiency
    Xiang, Jing
    Liu, Xueni
    Hao, Yue
    Zhu, Yanyan
    Wu, Minhua
    Lou, Jian
    Wang, Yonghui
    Xu, Chunwei
    Xie, Yanru
    Huang, Jianhui
    TRANSLATIONAL ONCOLOGY, 2023, 38
  • [5] Immune checkpoint inhibitors for the treatment of melanoma
    Sabbatino, Francesco
    Liguori, Luigi
    Pepe, Stefano
    Ferrone, Soldano
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (05) : 563 - 576
  • [6] Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review
    Baltussen, Joosje C.
    Welters, Marij J. P.
    Verdegaal, Elizabeth M. E.
    Kapiteijn, Ellen
    Schrader, Anne M. R.
    Slingerland, Marije
    Liefers, Gerrit-Jan
    van der Burg, Sjoerd H.
    Portielje, Johanneke E. A.
    de Glas, Nienke A.
    CANCERS, 2021, 13 (24)
  • [7] PREDICTING PRIMARY RESISTANCE AND EXPLORING MECHANISMS IN PATIENTS WITH ADVANCED MELANOMA TREATED WITH IMMUNE CHECKPOINT INHIBITORS (ICIS)
    Long, Georjna A. O.
    Tang, Tracy
    Apfel, Abraham
    Paulucci, David
    Chasalow, Scott
    Tenney, Daniel
    Fusaro, Gina
    Schadendorf, Dirk
    Tawbi, Hussein
    Hodi, F. Stephen
    Thakkar, Pratik
    Larkin, James
    Wolchok, Jedd
    Wind-Rotolo, Megan
    Huang, Shu-Pang
    Mohr, Peter
    Robert, Caroline
    Hoeller, Christoph
    Grob, Jean-Jacque
    Gogas, Helen
    Weber, Jeffrey
    Chang, Han
    Moss, Rebecca
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A639 - A640
  • [8] Diabetes Induced by Immune Checkpoint Inhibitors (ICIs)
    Verges, Bruno
    ANNALES D ENDOCRINOLOGIE, 2023, 84 (03) : 351 - 351
  • [9] Immune Checkpoint Inhibitors (ICIs)-Related Cardiotoxicity
    Zarifa, Abdulrazzak
    Lopez-Mattei, Juan
    Palaskas, Nicolas
    Iliescu, Cezar
    Durand, Jean-Bernard
    Kim, Peter Y.
    IMMUNOTHERAPY, 3RD EDITION, 2020, 1244 : 277 - 285
  • [10] Efficacy and toxicities of immune checkpoint inhibitors (ICIs) in advanced melanoma: A single institution experience
    Welaya, Karim
    Baran, Andrea M.
    Lekkala, Manidhar Reddy
    Sahasrabudhe, Deepak M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
12345